DYN
Dyne Therapeutics, Inc Earnings
$18.64
Earnings Summary
Revenue | $0Mn |
Net Profits | $-111.96Mn |
Net Profit Margins | -Inf% |
Dyne Therapeutics, Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Dyne Therapeutics, Inc has generated NaN% jump in its revenue since last 3-months.
Dyne Therapeutics, Inc’s net profit fell -25.03% since last year same period to $-111.96Mn in the Q4 2025. On a quarterly growth basis, Dyne Therapeutics, Inc has generated -3.62% fall in its net profits since last 3-months.
Dyne Therapeutics, Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, Dyne Therapeutics, Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.83 |
EPS Estimate Current Year | -0.83 |
Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current quarter stand at -0.83 - a -7.47% fall from last quarter’s estimates.
Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current year stand at -0.83.
Key Ratios
Earning Per Share (EPS) | 0 |
Dyne Therapeutics, Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Dyne Therapeutics, Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-04-30 | -0.83 | 0 | 100% |
